CFP and neoplasm: Previous studies have shown that CFP is a ligand of NK cell activation receptor NKp46 18, indicating that CFP can not only remove tumor cells through complement activation, but also promote the removal of tumor cells by promoting phagocytosis and removal of target cells without activated complement.